Authors: TOMIROTTI M DIMAIUTA M CONFALONIERI M SCANNI A

Citation: M. Tomirotti et al., EFFICACY AND TOLERABILITY OF NASALLY ADMINISTERED COMPARED TO PARENTERALLY ADMINISTERED METOCLOPRAMIDE IN THE SYMPTOMATIC TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS IN CANCER OUTPATIENTS - A CONTROLLED CLINICAL-STUDY, Supportive care in cancer, 2(6), 1994, pp. 389-392

Authors: TOMIROTTI M GRAMEGNA G MANTELLINI P FOSSATI V MEZZETTI M DIMAIUTA M SCANNI A

Citation: M. Tomirotti et al., CONCURRENT CARBOPLATIN (CBDCA), VINDESINE (VDS) AND RADIOTHERAPY IN STAGE-III NON-SMALL-CELL LUNG-CANCER (NSCLC), Tumori, 79(1), 1993, pp. 49-57

Authors: SCAGLIONE F SCANNI A TOMIROTTI M DIMAIUTA M FERRARI P FRASCHINI F

Citation: F. Scaglione et al., PHARMACOKINETICS AND BIOAVAILABILITY OF METOCLOPRAMIDE NASAL SPRAY VERSUS METOCLOPRAMIDE INTRAVENOUS IN HEALTHY-VOLUNTEERS AND CANCER-PATIENTS, Arzneimittel-Forschung, 43-2(9), 1993, pp. 986-988